Open Save New
FeedNavigator / National Library of Health Sciences
Tutkijat / Kuopio
AddAiraksinen, O(lavi)
AddAlhava, E.
AddAlhonen, L.
AddAtalay, M(ustafa)
AddCederberg, H.
AddDunkel, L(eo)
AddEskelinen, M(atti)
AddGiniatullin, R.
AddGröhn, O(lli)
AddHarno, K.
AddHartikainen, J(aana).
AddHartikainen, J(uha).
AddHarvima, I.
AddHiltunen, M(ikko)
AddJääskeläinen, J(uha) E.
AddJäkälä, P(ekka)
AddJänne, J.
AddJantunen, E(sa)
AddJärvinen, R.
AddJulkunen, P.
AddKaikkonen, M(inna) U.
AddKauhanen, J(ussi)
AddKivipelto, M(iia)
AddKoistinaho, M.
AddKoivisto, T(imo)
AddKokki, H.
AddKönönen, M.
AddKosma, V(eli)-M(atti)
AddKröger, H.
AddKurl, S(udhir)
AddKuusisto, J(ohanna)
AddLaakso, M(arkku)
AddLakka, T(imo) A.
AddLapinlampi, N(iina)
AddLaukkanen, J(ari) (UEF/KSSHP)
AddLevonen, A(nna)-L(iisa)
AddLindgren, A(ntti) E.
AddLöppönen, H(eikki)
AddMannermaa, A.
AddManninen, H.
AddMecklin, J(ukka)-P(ekka)
AddMoilanen, L(eena)
AddMönkkönen, J.
AddMykkänen, H.
AddNuutinen, J.
AddPaajanen, H.
AddPaananen, J.
AddPalvimo, J.J.
AddPelkonen, J(ukka)
AddPihlajamäki, J(ussi)
AddPihlajamäki, M.
AddPitkänen, A(sla)
AddPunnonen, K.
AddRaatikainen K
AddRauramaa, R.
AddRissanen, T.T.
AddRoine, R(isto) P.
AddRyynänen, O.P.
AddSaarikoski, S.
AddSchwab, U(rsula)
AddSivenius, J.
AddSoininen, H(ilkka)
AddSoininen, P(asi)
AddSorri, I.
AddStancakova, A(lena)
AddSulkava, R.
AddSund, R(eijo)
AddTammi, M.
AddTanila, H(eikki)
AddTiihonen, J(ari)
AddUusaro, A.
AddUusitupa, M.
AddVanninen, R.
AddVaskilampi, T.
AddViinamäki, H(eimo)
AddVirtanen, M(arianna)
AddVoutilainen, R(aimo)
AddVoutilainen, S(ari)
AddWahlfors, J.
AddWirth, T.
AddWong, G.
AddYlä-Herttuala, S(eppo)

Scholar Chart >>

»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.Kosma, V(eli)-M(atti)613 dayssaveRefWorks
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.Kosma, V(eli)-M(atti)619 dayssaveRefWorks
Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors.Kosma, V(eli)-M(atti)662 dayssaveRefWorks
High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer.Kosma, V(eli)-M(atti)695 dayssaveRefWorks
Predicting breast cancer risk using interacting genetic and demographic factors and machine learning.Kosma, V(eli)-M(atti)816 dayssaveRefWorks
MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.Kosma, V(eli)-M(atti)818 dayssaveRefWorks
High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.Kosma, V(eli)-M(atti)823 dayssaveRefWorks
Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools.Kosma, V(eli)-M(atti)828 dayssaveRefWorks
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.Kosma, V(eli)-M(atti)997 dayssaveRefWorks
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.Kosma, V(eli)-M(atti)1204 dayssaveRefWorks
Genome-wide association study of germline variants and breast cancer-specific mortality.Kosma, V(eli)-M(atti)1317 dayssaveRefWorks
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.Kosma, V(eli)-M(atti)1384 dayssaveRefWorks
Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls.Kosma, V(eli)-M(atti)1488 dayssaveRefWorks
Tumor-infiltrating lymphocytes associate with outcome in non-endemic nasopharyngeal carcinoma: a multicenter study.Kosma, V(eli)-M(atti)1533 dayssaveRefWorks
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Kosma, V(eli)-M(atti)1565 dayssaveRefWorks
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.Kosma, V(eli)-M(atti)1684 dayssaveRefWorks
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.Kosma, V(eli)-M(atti)1726 dayssaveRefWorks
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.Kosma, V(eli)-M(atti)1745 dayssaveRefWorks
Body mass index and breast cancer survival: a Mendelian randomization analysis.Kosma, V(eli)-M(atti)1754 dayssaveRefWorks
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.Kosma, V(eli)-M(atti)1788 dayssaveRefWorks
Association analysis identifies 65 new breast cancer risk loci.Kosma, V(eli)-M(atti)1804 dayssaveRefWorks
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Kosma, V(eli)-M(atti)1804 dayssaveRefWorks
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.Kosma, V(eli)-M(atti)1906 dayssaveRefWorks
Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice.Kosma, V(eli)-M(atti)1968 dayssaveRefWorks
Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.Kosma, V(eli)-M(atti)2026 dayssaveRefWorks
BRCA2 hypomorphic missense variants confer moderate risks of breast cancer.Kosma, V(eli)-M(atti)2030 dayssaveRefWorks
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.Kosma, V(eli)-M(atti)2060 dayssaveRefWorks
Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.Kosma, V(eli)-M(atti)2083 dayssaveRefWorks
Genome-wide association study identifies novel breast cancer susceptibility loci.Kosma, V(eli)-M(atti)2139 dayssaveRefWorks
rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk.Kosma, V(eli)-M(atti)2146 dayssaveRefWorks
Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.Kosma, V(eli)-M(atti)2158 dayssaveRefWorks
Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.Kosma, V(eli)-M(atti)2186 dayssaveRefWorks
High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.Kosma, V(eli)-M(atti)2193 dayssaveRefWorks
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Kosma, V(eli)-M(atti)2203 dayssaveRefWorks
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.Kosma, V(eli)-M(atti)2215 dayssaveRefWorks
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).Kosma, V(eli)-M(atti)2215 dayssaveRefWorks
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.Kosma, V(eli)-M(atti)2216 dayssaveRefWorks
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.Kosma, V(eli)-M(atti)2229 dayssaveRefWorks
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.Kosma, V(eli)-M(atti)2230 dayssaveRefWorks
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.Kosma, V(eli)-M(atti)2233 dayssaveRefWorks
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.Kosma, V(eli)-M(atti)2265 dayssaveRefWorks
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.Kosma, V(eli)-M(atti)2272 dayssaveRefWorks
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.Kosma, V(eli)-M(atti)2305 dayssaveRefWorks
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.Kosma, V(eli)-M(atti)2348 dayssaveRefWorks
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.Kosma, V(eli)-M(atti)2357 dayssaveRefWorks
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.Kosma, V(eli)-M(atti)2359 dayssaveRefWorks
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.Kosma, V(eli)-M(atti)2368 dayssaveRefWorks
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Kosma, V(eli)-M(atti)2405 dayssaveRefWorks
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.Kosma, V(eli)-M(atti)2408 dayssaveRefWorks
Genetic predisposition to ductal carcinoma in situ of the breast.Kosma, V(eli)-M(atti)2418 dayssaveRefWorks
 XML / RSS feed
next »